Syndrome and Treatment Pharmacokinetics Research and Exploration Based on Microdialysis Method about Coronary Heart Disease with Syndrome of Intermin-gled Phlegm and Blood Stasis

ZHU Li-xia; LIANG Dong-hui

doi:10.13422/j.cnki.syfjx.2014160119

您当前的位置：

首页 >

文章列表页 >

Syndrome and Treatment Pharmacokinetics Research and Exploration Based on Microdialysis Method about Coronary Heart Disease with Syndrome of Intermin-gled Phlegm and Blood Stasis

更新时间：2024-01-04

- Syndrome and Treatment Pharmacokinetics Research and Exploration Based on Microdialysis Method about Coronary Heart Disease with Syndrome of Intermin-gled Phlegm and Blood Stasis
- Chinese Journal of Experimental Traditional Medical Formulae Vol. 20, Issue 16, Pages: 119-123(2014)
- 作者机构：
- 作者简介：
- 基金信息：
- DOI：10.13422/j.cnki.syfjx.2014160119
  CLC： R285.5
- Published：2014
- 稿件说明：
移动端阅览
ZHU Li-xia, LIANG Dong-hui. Syndrome and Treatment Pharmacokinetics Research and Exploration Based on Microdialysis Method about Coronary Heart Disease with Syndrome of Intermin-gled Phlegm and Blood Stasis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 119-123.
DOI：

ZHU Li-xia, LIANG Dong-hui. Syndrome and Treatment Pharmacokinetics Research and Exploration Based on Microdialysis Method about Coronary Heart Disease with Syndrome of Intermin-gled Phlegm and Blood Stasis[J]. Chinese journal of experimental traditional medical formulae, 2014, 20(16): 119-123. DOI： 10.13422/j.cnki.syfjx.2014160119.

摘要

目的：进行基于“实时、活体、动态、微创”特征的微透析采样技术的证治药动学探索性研究。方法： SD大鼠通过连续7周给予高脂饲料并结扎冠状动脉左前降支复制痰瘀互结型冠心病模型。正常组和痰瘀互结型冠心病组、丹参素高、低剂量组，每组各6只大鼠，提取物中丹参素的给药量为分别为25.3，50.6 mg·kg-1，进行正常和冠心病大鼠的证治药动学研究。单次灌胃给药后，血液微透析法活体、动态采样，高效液相色谱法检测微透析样品丹参素的浓度，采用非房室模型处理获得药动学参数。结果：模型组大鼠血清总胆固醇（TC）、甘油三酯（TG）、血清肌酸磷酸激酶（CK）升高，高、中、低切变率下全血黏度升高，与正常组差异具有统计学意义（P<0.01）。获取了不同机能状态下丹参素的药动学特征。和正常组相比，痰瘀互结型冠心病大鼠丹参素达峰浓度（Cmax）增加，但无统计学意义；达峰时间（Tmax）缩短，零阶矩（AUC）、一阶矩曲线下面积（AUMC）增加，和正常组相比，结果具有统计学意义（P<0.05）。结论：本研究模式可为类似证治药动学研究做借鉴。

Abstract

Objective: The syndrome and treatment pharmacokinetics model was carried out based on the ‘real-time

dynamic

minimally invasive

in vivo’ microdialysis sampling method. Method: The intermin-gled phlegm and blood stasis syndrome coronary heart disease SD rats model was replicated by feeding with high fat diet for 7 weeks combined with left anterior descending branch coronary artery ligation. The normal group and the model group were was divided into high and low dose group with 6 rats in each group

the extract of Danshensu dosage was respectively 25.3

50.6 mg· kg-1. The pharmacokinetics study was carried out on normal and coronarg heatt disease(CHD) rats by intragastric administration of different dose. The Danshensu concentration of microdialysis samples were detected with HPLC and the pharmacokinetic parameters was obtained using noncompartmental model. Result: The results showed that serum total cholesterol(TC)

triglyceride(TG)

creatine phosphokinase(CK) in the model group increased

blood viscosity of high

medium and low shear also increased. The results had highly statistically significant differences compared with the normal group(P<0.01).The results showed that Danshensu peak concentration increases

but without statistical significance

the peak time shorten

area under the curve(AUC) and area under the first moment curve(AUMC) increases in CHD rats comparing with the normal group

the results were statistically significant(P<0.05). Conclusion: This study can be the reference for the similar research mode.

关键词

Keywords

references

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Investigation of Systematic Stability of Danshen Capsules

Intestine Absorption StudyonDanshensuandSalvianolic AcidBwithRat SinglePassPerfusionModel

Synchronous Pharmacokinetics Study on Effects of Shouwu Fang on Levodopa in Blood and in Extracellular Fluids of Striatum in Rats with Parkinson’s Disease

Related Author

Feng-lian ZHANG

Shun-nan ZHANG

Zheng-liang YE

Tao WANG

Li-hong ZHOU

Anna Rita Bilia2

Franco Francesco Vincieri2

HUANG Lu-qi1

Related Institution

School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine (TCM)

National & Local United Engineering Laboratory for TCM Advanced Manufacturing Technology, Tasly Pharmaceutical Co. Ltd.

College of Chinese Materia Medica,Guangdong Pharmaceutical University

Institute of Chinese Materia Medica,China Academy of Chinese Medical Science

The Guangzhou University of Traditional Chinese Medicine

AI问答

Postal code：100700
Tel：010-84076882 Email：syfjx_2010@188.com
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备11006657号-10 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰